Zealand Pharma A/S (CPH:ZEAL)
252.30
-74.00 (-22.68%)
Jun 8, 2026, 4:59 PM CET
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 22.92 billion as of June 8, 2026. Its market cap has decreased by -20.52% in one year.
Market Cap
22.92B
Enterprise Value
8.87B
Revenue
9.24B
Ranking
n/a
PE Ratio
3.65
Stock Price
252.30
Market Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 1.41B to 22.92B, an increase of 1,530.41%. That is a compound annual growth rate of 19.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 22.92B | -30.24% |
| Dec 30, 2025 | 32.85B | -35.01% |
| Dec 30, 2024 | 50.55B | 132.03% |
| Dec 29, 2023 | 21.79B | 110.16% |
| Dec 30, 2022 | 10.37B | 65.31% |
| Dec 30, 2021 | 6.27B | -28.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.26T |
| Genmab | 97.22B |
| Coloplast | 86.40B |
| ALK-Abelló | 58.98B |
| Demant | 53.19B |
| H. Lundbeck | 42.96B |
| Ambu A/S | 17.48B |
| Bavarian Nordic | 13.97B |